Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cannara Biotech Inc. LOVFF


Primary Symbol: V.LOVE

Healthcare Cannabis
Cannara Biotech Inc. is a Canada-based vertically integrated producer of premium-grade cannabis and cannabis-derivative products for the Quebec and Canadian markets. It operates through its wholly owned subsidiaries, Cannara Biotech (Quebec) Inc. and Cannara Biotech (Valleyfield) Inc. The Company owns two mega facilities based in Quebec spanning over 1,650,000 square feet, providing the Company... see more

Recent & Breaking News (TSXV:LOVE)

Cannara Biotech Announces Record-Breaking Q1 2024 Results: Continued Robust Growth and Market Expansion

PR Newswire January 30, 2024

Cannara Biotech Announces Engagement of Market Maker Services from Independent Trading Group ("ITG")

PR Newswire January 8, 2024

Cannara Biotech Announces Notice Of Annual General Meeting Of Shareholders To Be Held Virtually On January 25th, 2024

PR Newswire December 13, 2023

Cannara Biotech to Host Investor Webcast on Thursday December 14th, 2023

PR Newswire December 11, 2023

Cannara reports record growth and profitability in Q4 2023

Jonathon Brown December 7, 2023

Cannara Biotech Reports Fourth Quarter and 2023 Fiscal Year Results: Record Growth and Profitability Continues

PR Newswire December 7, 2023

Cannara Biotech Inc. Reports Record Q3 2023 Financial Results with Net Revenues of $15.9 Million and Net Income of $2.9 million

PR Newswire July 27, 2023

Cannara Biotech Inc Announces Participation in the LD Micro Invitational XIII

Newsfile May 23, 2023

Cannara Biotech Inc. To Participate At Canaccord Genuity's 7th Annual Global Cannabis Conference

PR Newswire May 11, 2023

CANARA BIOTECH INC. SECURES AN ADDITIONAL $10 MILLION IN NON-DILUTIVE CAPITAL WITH ITS LEAD CREDIT PROVIDER, BMO COMMERCIAL BANKING

PR Newswire May 4, 2023

Cannara Biotech Inc. to Host Investor Webcast on May 4th, 2023

PR Newswire April 25, 2023

Cannara Biotech Inc. reports Q2 2023 Financial Results with quarterly net revenues of $13 million, a 76% increase compared to Q2 2022

PR Newswire April 24, 2023

Cannara Biotech Inc. Enters into an Automatic Share Purchase Plan

PR Newswire February 28, 2023

Cannara Biotech Inc. Reports Q1 2023 Financial Results

PR Newswire January 23, 2023

Cannara Announces Proposed Share Consolidation

PR Newswire January 12, 2023

Cannara Announces Normal Course Issuer Bid for Common Shares of the Corporation

PR Newswire November 30, 2022

Cannara Biotech (TSXV:LOVE) reports fourth quarter financial results

Simon Druker  November 25, 2022

Cannara Biotech Inc. Reports Record Q4 and 2022 Fiscal Year Financial Results

PR Newswire November 25, 2022

Cannara Releases 14 New SKU's Across Ontario and Quebec

PR Newswire September 30, 2022

Cannara Biotech (TSXV:LOVE) enters B.C. market & launches its 1st vape cartridge & accessory

Jonathon Brown September 20, 2022